Abstract. The present study describes circular RNA (circRNA) profiles in three pairs of hepatocellular carcinoma (HCC) tissues and the corresponding adjacent non-tumorous tissues (NTs) by microarray. circRNA is a type of endogenous RNA that serve a crucial role in disease development and aberrantly express in a number of types of cancer. In the present study, 3 paired HCC tissues and paired adjacent NTs were collected from HCC surgical specimens from 3 hepatitis B virus-infected patients with HCC. With abundant and varied probes accounting for 5,396 circRNAs, a large number of circRNAs are able to be quantitatively determined. Based on the microarray data, 222,567,556 upregulated circRNAs and 125,439,219 downregulated circRNAs were identified respectively. Further analysis revealed 24 upregulated and 23 downregulated significantly circRNAs (fold-change ≥2; P≤0.05) in HCC tissues compared with NTs. By means of computer analysis and database inquiring, the microRNA (miRNA) response elements associated with the abnormally expressed circRNAs were annotated. The present study showed novel evidence determining genome-wide circRNA expression patterns in HCC using microarray analysis. The results demonstrated that clusters of circRNAs were aberrantly expressed in HCC compared with NTs. These circRNAs may be involved in the occurrence and development of HCC. Therefore, the results of the present study may provide a novel approach for improving the understanding of the molecular basis of HCC. Furthermore, the identified circRNAs may be potential biomarkers for the diagnosis of HCC.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common type of cancer worldwide, ranking fifth and eighth in males and females, respectively, and exhibits one of the highest mortality rates (1) . Hepatitis B virus (HBV) and hepatitis C virus (HCV) are primary causes of HCC. Chronic HBV infection is a dominant risk factor in the majority of areas of Asia and Sub-Saharan Africa that have a high incidence of HCC (2) . The majority of patients with HCC whoexperience HBV infectionexhibit cirrhosis, secondary to the chronic necroinflammation (3) . HBV, an oncogenic virus, promotes HCC via indirect (necroinflammation and regeneration injury) and direct (integration of its DNA in the host genome) pathways (4) . The aberrant expression of genes and regulatory RNA moleculesare key nodes for the occurrence and development of HCC.
Circular RNAs (circRNA/ciR), initially observed in RNA viruses in the 1970s, have been identified as unique non-coding RNA molecules (5) . CircRNAsare a type of endogenous RNA with a stable structure and tissue-specific expression (6) and are widely present in the cytoplasm of eukaryotic organisms, in the circular form (7) . CircRNA forms a covalently closed continuous loop by means of unique non-canonical 'head-to-tail' splice without a free 3' or 5' end (8) (9) (10) . CircRNAs derive from non-linear reverse splicing or gene rearrangement and circRNAs dominate the total spliced transcripts (11) . High-throughput sequencing has enabled >25,000 types of circRNAs to be discovered in human fibroblasts (12) . In addition, circRNAs may be formed in exons and introns, and cirRNAs with either origin may function in the regulation of gene expression (13) .
A previous study demonstrated that circRNA served a role in the level of miRNA-mediated regulation of gene expression by sequestering the miRNAs. Furthermore, circRNAs are able to regulate gene expression by acting as competing endogenous RNAs and also termed miRNA 'sponges' (14) . CircRNAs contain multiple, tandem miRNA binding sites. CircRNAs adsorb and sequester miRNAs to terminate the suppression of their targets, and to modulate the expression levels of other associated RNA molecules which share the same miRNA response elements (MREs) (14) (15) (16) . The interaction between circRNAs and disease-associated miRNAs indicates that circRNAs are important for disease regulation (17) .
CircRNAs serve crucial roles in the development of diseases, including nervous system disorders and atherosclerosis (18, 19) . In addition, circRNAs have been demonstrated to be involved in the neoplastic process (20) ; however, the molecular mechanisms underlying the association of circRNAs with cancer remain unclear (21) .
To the best of our knowledge, a large-scale microarray screening of HCC and the focus of circRNAs as biomarkers of HCC has not been previously reported. The present study screened dysregulated circRNAs expression in HCC tissues using a microarray and annotated them for circRNA/microRNA (miRNA/miR) interactions.
Patients and methods
Patients and clinical specimens. The total three paired HCC tissues and adjacent non-tumorous tissues (NTs ; Table I) were collected from HCC surgical specimens between June 2012 and December 2013 at Beijing YouAn Hospital, Capital Medical University (Beijing, China). All tissue specimens were immediately preserved in RNA-fixer reagent (BioTeke Corporation, Beijing, China) following removal from the body and were stored at -80˚C until use. The corresponding adjacent NTs were taken 5 cm from the edge of the cancer and contained no obvious tumor cells, as evaluated by an experienced pathologist.
All three HCC patients were diagnosed with HBV infection. Tumors were staged according to the tumor-node-metastasis (TNM) staging system (22) . The three patients were diagnosed with T1N0M0, T1N0M0, and T3aN0M0, respectively (Table I) . No radiotherapy, chemotherapy or targeted therapy was administered prior to surgery.
The present study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of Beijing YouAn Hospital, Capital Medical University (Beijing, China). Written informed consent was obtained from all participants.
Total RNA extraction, labeling, hybridization, and array scanning. Total tissue RNA was extracted from the HCC tissues and paired adjacent NTs using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), following the manufacturer's protocol. CircRNAs were treated with RNase R (Epicentre; Illumina, Inc., San Diego, CA, USA) to remove linear RNAs, according to the manufacturer's protocol. Each sample was amplified and transcribed into fluorescent complementary RNA utilizing a random priming method (Arraystar Super RNA Labeling kit; Arraystar, Inc., Rockville, MD, USA). The labeled circRNAs were hybridized onto the Arraystar Human circRNA Array (5,396 human circRNA probes; cat. no. 6x7K; Arraystar, Inc.).
The labeled circRNAs were purified using an RNeasy Mini kit (Qiagen, Inc., Valencia, CA, USA). The concentration and specific activity of the labeled circRNAs (pmol Cy3/µg circRNA) were measured using NanoDrop ND-1000 spectrophotometer (NanoDrop; Thermo Fisher Scientific, Inc., Wilmington, DE, USA). A total of 1 µg of each labeled circRNA was dispensed into the gasket slide and assembled to the circRNA expression microarray slide. The slides were incubated for 17 h at 65˚C in an Agilent Hybridization Oven (Agilent Technologies, Inc., Santa Clara, CA, USA). The hybridized arrays were washed, fixed and scanned using the Axon GenePix 4000B microarray scanner (Molecular Devices, Sunnyvale, CA, USA).
Detection of expression profiling data and differentially expressed data. Scanned images were imported into GenePix Pro version 6.0 software (Axon; Molecular Devices) for grid alignment and raw data extraction. Quantile normalization of raw data and subsequent data processing were performed using the R software package (version 3.1.2; Lucent Technologies, Inc.; Nokia, Espoo, Finland). Low-intensity filtering was performed, and the circRNAs with ≥2 of the 6 samples having 'flags expressed' (≥2 times background standard deviation) were retained for further analysis. The analysis outputs were filtered and the differentially expressed circRNAs were ranked according to fold-change and P-value. Differentially expressed circRNAs were filtered and illustrated as a volcano plot. Hierarchical clustering was performed to reveal the distinguishable circRNAs expression pattern among samples.
Annotation for circR NA /miR NA interaction. T he circRNA/miRNA interaction was predicted using Target Scan (www.targetscan.org/vert_71) and Miranda (www.microrna. org/microrna/home.do). All differentially expressed circRNAs were annotated in detail using the circRNA/miRNA interaction information.
Statistical analysis. All data were analyzed using SPSS (version 21.0; IBM Corp., Armonk, NY, USA) and all results were presented as the mean ± standard deviation. Differences between two groups were estimated using the Student's t-test, and fold-change ≥2.0 and P≤0.05 were considered to indicate a statistically significant difference.
Results

circRNA expression profiles.
A total of 5,396circRNAs were scanned and the array image of each sample was demonstrated. Quantile normalization of raw data and subsequent data processing were performed using the R software package. The data demonstrated that 222,567,556 circRNAs were upregulated (fold-change ≥2) and 125,439,219 circRNAs were downregulated (fold-change ≥2; Fig. 1 ).
Differentially expressed circRNAs. The differentially expressed circRNAs with statistical significance between the two groups (HCC tissues group vs. NT group) were identified through using volcano plot filtering. A total of 24 upregulatedcircRNAs and 23 downregulated circRNAs were identified to be significant in HCC tissues compared with NTs (fold-change ≥2; P≤0.05; Fig. 2 ; Tables II and III) . The top five upregulated circRNAs were hsa_circRNA_104351, h s a _ c i r c R N A _ 10 2 814 , h s a _ c i r c R N A _ 10 3 4 8 9, hsa _ ci rcR NA _102109 a nd hsa _ ci rcR NA _10 0381. Furthermore, the top five downregulated circRNAs were hsa _circR NA _10 0327, hsa _circR NA _101764, hsa_circRNA_101092, hsa_circRNA_001225 and hsa_ circRNA_102904.
Annotation for circR NA /miR NA interactions. The circRNA/miRNA interaction was predicted using the miRNA target prediction software. All differentially expressed circRNAs (fold-change ≥2; P≤0.05) were annotated in detail using the circRNA/miRNA interaction information (Tables IV  and V) . The most upregulated circRNA, hsa_circRNA_104351, adjusts its MREs: hsa-miR-490-5p, hsa-miR-876-5p, hsa-miR-619-3p, hsa-miR-619-3p, hsa-miR-331-3p and hsa-miR-411-3p. Similarly, the most downregulated circRNA, hsa_circRNA_100327, targets the following MREs: Hsa-miR-637, hsa-miR-326, hsa-miR-330-5p, hsa-miR-646 and hsa-miR-24-3p.
Discussion
Previously, circRNAs have been identified to serve a role in a number of types of disease, including cancer. The majority of circRNAs exhibit distinct tissue/developmental-stage and diseases-specific expression in the process of organismal hsa-miR-9-5p
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differentiation, development and diseases (6 (49) and ovarian cancer (50) . Abnormal circRNAs have been identified to be involved in the occurrence and development of HCC (51) . In a previous study, the RNA-seq data from 50 paired HCC tissues and NTs were analyzed to identify the function of circRNAs in HCC (51) . Protein-coding genes (PCGs) associated with the 2091 circRNAs were identified to be enriched predominantly on liver/cardiovascular-related diseases, and participated in a number of metabolic processes (51) . A total of 45 circRNAs and 23 PCGs exhibited significant expression alterations between HCC and normal tissues (51) .
Representative circRNA, antisense to cerebellar degeneration-related protein 1 (Cdr1as, also termed ciRS-7), has been identified to act as an oncogene through targeting miR-7 in HCC (52). Cdr1as expression was upregulated and miR-7 expression was downregulated in HCC tissues. Knockdown of Cdr1as downregulated the expression of miR-7, and inhibited the expression of Cyclin E1 (CCNE1) and phosphatidylinositol 3-kinase catalytic subunit delta (PIK3CD), resulting in the suppression of proliferation and invasion of HCC cells through targeting miR-7 (52). Increased Cdr1as expression was significantly associated with hepatic microvascular invasion (MVI), alpha-fetoprotein (AFP) level, younger age and deterioration of HCC. The expression of Cdr1as in HCC tissues with concurrent MVI was inversely associated with miR-7 and positively associated with two miR-7-targeted genes (PIK3CD and p70S6K) (53) .
The expression of circZKSCAN1 (zinc finger with KRAB and SCAN domains 1) and ZKSCAN1mRNA was significantly decreased in the HCC samples compared with matched adjacent non-tumorous tissues. The circZKSCAN1 levels varied in patients with tumor numbers, cirrhosis, vascular invasion and the tumor grade. ZKSCAN1mRNA primarily regulated cellular metabolism, whereas circZKSCAN1 mediated a number of cancer-related signaling pathways, suggesting a non-redundant role for ZKSCAN1mRNA and circZKSCAN1 (54) .
CircRNAs are abundant, evolutionally conserved and relatively stable in the cytoplasm and therefore may be valuable for cancer diagnosis (12, 14) . A previous study demonstrated that a total of 174 and 353 circRNAs were upregulated and downregulated in HCC tissues, respectively, according to microarray analysis (55) . hsa_circ_0004018 may be involved in cancer-related pathways via interactions with miRNAs (55) . hsa_circ_0004018 is downregulated in HCC tissues and HCC lines, and a decreased hsa_circ_0004018 level is associated with serum AFP level, tumor diameters, differentiation, Barcelona Clinic Liver Cancer stage (56) and TNM stage. An additional study identified that hsa_circ_0001649 expression was significantly downregulated in HCC tissues, using the reverse transcription-quantitative polymerase chain reaction (RT-qPCR) (57) . hsa_circ_0001649 expression was associated with tumor size and the occurrence of tumor embolus in HCC; therefore, hsa_circ_0001649 may function in the tumorigenesis and metastasis of HCC and serve as a novel potential biomarker (57) . In addition, GO analysis revealed that hsa_circ_0005075 may participate in cell adhesion during HCC development. Upregulated hsa_circ_0005075 exhibited an association with HCC tumor size and revealed diagnostic potential (58) .
The present study compared the circRNA expression profiles between HCC tissue and adjacent NTs using microarray analysis with 5,396 circRNA probes. On the basis of the microarray data, 222,567,556 upregulated circRNAs and 125,439,219 downregulated circRNAs were identified in HCC tissues compared with adjacent NTs. Further analysis identified 24 upregulated and 23 downregulated significantly circRNAs (fold-change ≥2; P≤0.05) in HCC tissues compared with NTs. The results of the present study demonstrated that the circRNA expression profiles of HCC tissues differ from that of NTs.
Computer and database analysis annotated the MREs associated with the abnormally expressed circRNAs. The upregulated circRNAs may suppress miRNA expression. On the contrary, downregulated circRNAs may increase miRNA expression. The circRNAs, as a sponge for miRNAs, may be associated with the occurrence and progression of HCC, and may provide a novel approach to identify the underlying molecular basis of HCC. Furthermore, the identified differentially expressed circRNAs may be used as biomarkers for HCC.
In the present study, the abnormal expression levels of three paired HCC tissues were analyzed. Additional studies, with larger cohorts and using RT-qPCR, are required to validate the results from the present study. The data from the present study indicated that abnormal expression of certain circRNAs in HCC tissues and abnormal circRNAs may be novel biomarkers for the diagnosis of HCC.
